PTCOG-AO Program

The Future of Particle Therapy in the Asia-Oceania Region at PTCOG 62

The PTCOG-AO Program at PTCOG 62 offers a unique opportunity to explore the latest advancements in particle therapy specific to the Asia-Oceania region.

Attendees will gain an in-depth understanding of the innovative treatment strategies and clinical evidence emerging from Asia-Oceania that are shaping the future of particle therapy worldwide. The program will cover a variety of topics, including the latest trends in treating predominant cancers in Asia, such as pediatric, oral, oropharyngeal, head and neck cancers, as well as chordoma and sarcoma.

View Program

Join us 11 June, 14:00-17:15, Hall 331

Highlight Sessions from the PTCOG-AO Program

14:10 - 14:20

Asia-Oceania Particle Therapy Survey Results

A significant opening discussion will be led by Dongho Shin, revealing the latest insights from the Asia-Oceania Particle Therapy Survey. This session will provide a comprehensive overview of regional trends and advancements, setting the stage for understanding current practices and future directions in particle therapy across Asia and Oceania.

14:35 - 14:55

Proton Therapy for Oral and Oropharyngeal Cancers

Sapna Nangia will delve into the application of proton therapy in treating oral and oropharyngeal cancers, highlighting successful treatment protocols and emerging research from India. This session will offer critical insights into the effectiveness of particle therapy in treating complex cancer types, which are prevalent in the region.

16:00 - 17:15

Disseminating Clinical Evidence from Asia-Oceania

This segment will explore how countries like Japan, Taiwan, and Thailand are advancing their particle therapy capabilities. Presentations will discuss the development of national registries, the integration of new clinical trials, and the synthesis of current research, providing a roadmap for enhancing particle therapy practices through robust clinical evidence.

Connect with leading specialists and share knowledge

Join us and explore the potential of particle therapy and how it revolutionizes cancer treatment in Asia-Oceania.